
Why Healthline chooses Cornbread Hemp for pain relief
Christy Snyder has tested over 50 CBD brands and 100 CBD products for Healthline. She praised Cornbread Hemp Distilled Oil for helping her manage anxiety and insomnia, noting benefits for physical tension and back pain.
'About an hour after taking this oil, I felt both physically and emotionally less anxious and tense, which helped me to fall asleep. For me, when I can reduce my physical symptoms of anxiety (tension in my shoulders and neck, heart racing), it helps to slow down and decrease any intrusive or racing thoughts.'
'I've also been dealing with some back pain, and I noticed that this reduced some of the pain.'
Christy was a fan of the flavor. 'I found this oil to have a buttery taste — maybe from the MCT oil, but it was stronger in flavor than other oils I've tried. I really liked that it tasted buttery — I am a lover of movie theater butter popcorn. I didn't notice much of a hemp-y taste, which was pleasant.'
She also considers Cornbread Hemp to be great value for money. 'This oil is SUPER affordable for the typical price/contents of a full-spectrum CBD oil. Some of them go for $100+, and this one is under $100 by quite a bit. It's great value, and I like that it's USDA organic.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
35 minutes ago
- Medscape
Probiotics, Prebiotics Tied to Decreased Depression, Anxiety
The use of probiotics and prebiotics, alone or combined (synbiotics), was associated with a significantly greater decrease in symptoms of depression and anxiety in patients with depression compared to nonuse, a new meta-analysis showed. METHODOLOGY: Researchers included 19 studies involving more than 1400 adults with mild-to-moderate depression or major depressive disorder, of whom 523 acted as the control group. In addition to assessing the effect of probiotics, prebiotics, and synbiotics on depression scores, the investigators also assed their effect on anxiety in seven of the included studies (n = 481). Risk for bias was evaluated using the Cochrane Collaboration's tool. TAKEAWAY: Compared with control individuals, participants receiving probiotics, prebiotics, or synbiotics had a significantly greater decrease in depression scores (standardized mean difference [SMD], -1.8; 95% CI, -2.4 to -1.1) and anxiety scores (SMD, -1.6; 95% CI, -2.8 to -0.4). Subgroup analyses indicated significant between-group differences for depression scores on the basis of nationality, intervention duration, disease severity, and BMI and for anxiety scores on the basis of nationality, age, assessment tool, and number of strains. However, six of the 19 studies showed some concerns for risk for bias. IN PRACTICE: Although the current analysis suggested a promising role for these substances, future studies 'should focus on comparing probiotics, prebiotics, and synbiotics to standard treatments, identifying effective strains, and incorporating objective measures better to understand their impact on depression and anxiety symptoms,' the investigators wrote. SOURCE: This study was led by Reza Moshfeghinia, MD, MPH, Shiraz University of Medical Sciences, Shiraz, Iran. It was published online on May 24 in Journal of Psychiatric Research . LIMITATIONS: Significant heterogeneity existed in the diagnosis of depression among the included studies, with variation in diagnostic criteria and assessment tools potentially influencing the results. Additional limitations included the use of various strains and doses of probiotics, prebiotics, and synbiotics; reliance on self-reported measures; and the lack of objective data in some studies. DISCLOSURES: The investigators reported having no relevant conflicts of interest.


Fox News
36 minutes ago
- Fox News
A New Approach To Driving Down Drug Prices
The cost of healthcare is a concern nationwide, but Arkansas is trying to lead the way in bringing price relief to patients, particularly when it comes to prescription drugs. Governor Sarah Huckabee Sanders recently signed a new law banning pharmacy benefits managers from owning and operating pharmacies in her state. PBMs are third-party companies that act as intermediaries or middlemen between insurance companies, big pharma, and pharmacies and are supposed to negotiate for lower costs through rebates and discounts. However, President Trump and his administration have recently called them out for helping to drive up the price of drugs in the country. Governor Sarah Huckabee Sanders joins the Rundown to explain her state's efforts to get prices down and how she hopes other states and the federal government will follow Arkansas's lead. While the President's tariff strategy and efforts to reshape what he sees as an unfair trade system have created some uncertainty on both Wall Street and Main Street, the latest jobs data suggest the labor market is holding steady. Many investors took Friday's May jobs report as a sign that a recession isn't imminent. However, the housing market, inflation, interest rates, and other factors are still a concern. FOX Business Network's Gerri Willis joins the Rundown to discuss the state of the economy, including why she believes the housing market is under pressure but remains optimistic about the American consumer. Plus, commentary from RNC Youth Advisory Council Chair, Brilyn Hollyhand. Learn more about your ad choices. Visit


Washington Post
44 minutes ago
- Washington Post
Mothers report worse mental health in new report
More American mothers reported worse mental health in 2023 than in 2016 in a national survey, though many said they were in good health, according to a study in JAMA Internal Medicine. Using data from the National Survey of Children's Health, researchers analyzed self-reported mental health ratings from some 198,000 mothers with children age 17 and younger. In 2023, 26 percent of the mothers who responded said their mental health was 'excellent,' compared with 38 percent of mothers in 2016. While 19 percent of mothers reported good mental health in 2016, some 26 percent said the same in 2023.